including benign infantile sleep myoclonus, opisthotonic posturing due to spasticity, and gastro-oesophageal reflux. At the onset, spasms may be infrequent and occur singularly; however, within days, the spasms occur in clusters particularly upon awakening or on falling asleep. The clusters may consist of as few as five, or as many as 100 spasms with between three and 30 seconds between each spasm and may be followed by irritability and crying, lethargy, and drowsiness.5 This clustering of spasms is almost unique to this age group and tends to diminish over a period of months, disappearing in most children by the age of 2 years. In older children each spasm lasts longer and represents more a tonic seizure, one of the characteristic seizure types seen in the Lennox-Gastaut syndrome'.3
The electroencephalogram (EEG) Hypsarrhythmia is the characteristic EEG pattern seen in children developing spasms in the first year of life, and was recognised in the early 1950s.9 It consists ofhigh voltage (greater than 200 microvolts) and multifocal spikes, spike and wave discharges, chaotic slowing, and asynchrony. This activity may occur continuously or in bursts, may be absent in the waking state appearing only in non-rapid eye movement (non-REM) sleep, and disappearing in REM sleep. A sleep recording should therefore be obtained in infants suspected of having spasms particularly if an initial, or 'awake' EEG is non-specifically abnormal. The occurrence of a spasm during an EEG is frequently associated with a relative flattening (attenuation) or suppression of the trace, rather than by a spike discharge.7 Hypsar rhythmia is usually generalised but may be asymmetrical or even unilateral.'0 1 It is rarely seen after the age of 3 However, this belief may be ill founded as the ultimate prognosis depends primarily on the underlying aetiology; additional prognostic factors such as pre-existing neurodevelopment status, age of onset, and response to treatment are also in fact dependent upon the aetiology and can therefore not be regarded as significantly influencing the outcome per se. Most of the studies have not assessed response to treatment (with whatever agent) in relation to whether the spasms were symptomatic or cryptogenic, or to the underlying aetiology. Although there is limited evidence that at least in the less common cryptogenic (and perhaps particularly in idiopathic) cases, early treatment of spasms is associated with a more favourable outcome,'3 27 this is not necessarily cause and effect; infants with cryptogenic spasms may be treated earlier than patients with symptomatic spasms because the spasms are recognised earlier. The effect of prompt treatment is thus difficult to separate from that due to the 'severity' of the disorder. Finally there has been little attempt to assess the influence of different periods of treatment lag; most studies report lag periods of months which could arguably be associated with a less favourable response to treatment and outcome. However, a treatment lag of between one and two weeks is unlikely to influence outcome and could therefore be reasonably incorporated into a placebo controlled protocol. There is also an opinion that in some patients spasms may remit spontaneously.28 All of these factors militate against a rational evaluation of treatment of spasms.
However, it does appear to be true that spasms are resistant to many 'conventional' antiepileptic drugs. Most success has been achieved using the benzodiazepines (particularly nitrazepam),29 sodium valproate, 30 
Conclusion
The clinical description of spasms has not been improved upon since 1841; the pathogenesis remains unclear and the classification has been revised to include symptomatic, cryptogenic, and idiopathic cases. The development of improved anatomical, and, to a lesser extent functional, brain imaging has identified an increasing number of symptomatic cases. Until recently, the recommended treatment has relied upon drugs that have an unknown mechanism of action and serious side effects. Infantile spasms (particularly in the context of West's syndrome) demands a more scientifically precise study of its pathogenesis and treatment. This will almost certainly require a multicentre, even multinational collaboration in view of the relatively small numbers of children involved. This practical difficulty should not preclude the evaluation of what is arguably the most malignant epilepsy syndrome/seizure type of childhood. In the interim antiepileptic treatment should be used more rationally and selectively on the basis of the electroclinical pattern and underlying aetiology,'5 and in view of the recent and promising response to the newer antiepileptic drugs.
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